Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus

被引：0
|
作者：
H. L. Lutgers
E. G. Gerrits
R. Graaff
T. P. Links
W. J. Sluiter
R. O. Gans
H. J. Bilo
A. J. Smit
机构：
[1] University Medical Center Groningen,Department of Internal Medicine
[2] Diabetes Center,Department of Biomedical Engineering
[3] Isala Clinics,Department of Endocrinology
[4] University Medical Center Groningen,Department of Medicine
[5] University Medical Center Groningen,undefined
[6] University of Groningen,undefined
来源：
Diabetologia | 2009年 / 52卷
关键词：
Advanced glycation end-products; Complications; Fluorescence; Type 2 diabetes; UKPDS risk score;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [1] Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus
    Lutgers, H. L.
    Gerrits, E. G.
    Graaff, R.
    Links, T. P.
    Sluiter, W. J.
    Gans, R. O.
    Bilo, H. J.
    Smit, A. J.
    DIABETOLOGIA, 2009, 52 (05) : 789 - 797
  • [2] Skin autofluorescence is additive to the UKPDS risk-score in the prediction of cardiovascular complications in type 2 diabetes
    Lutgers, Helen L.
    Gerrits, Esther G.
    Bilo, Henk J.
    Smit, Andries J.
    DIABETES, 2007, 56 : A173 - A174
  • [3] Skin autofluorescence as a marker of tissue AGE accumulation has additional value to the UKPDS risk-score in predicting cardiovascular disease in type 2 diabetes
    Lutgers, H. L.
    Gerrits, E. G.
    Bilo, H. J.
    Smit, A. J.
    DIABETOLOGIA, 2007, 50 : S47 - S48
  • [4] External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
    van Dieren, S.
    Peelen, L. M.
    Noethlings, U.
    van der Schouw, Y. T.
    Rutten, G. E. H. M.
    Spijkerman, A. M. W.
    van der A, D. L.
    Sluik, D.
    Boeing, H.
    Moons, K. G. M.
    Beulens, J. W. J.
    DIABETOLOGIA, 2011, 54 (02) : 264 - 270
  • [5] External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
    S. van Dieren
    L. M. Peelen
    U. Nöthlings
    Y. T. van der Schouw
    G. E. H. M. Rutten
    A. M. W. Spijkerman
    D. L. van der A
    D. Sluik
    H. Boeing
    K. G. M. Moons
    J. W. J. Beulens
    Diabetologia, 2011, 54 : 264 - 270
  • [6] UKPDS 60 - Risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine
    Kothari, V
    Stevens, RJ
    Adler, AI
    Stratton, IM
    Manley, SE
    Neil, HA
    Holman, RR
    STROKE, 2002, 33 (07) : 1776 - 1781
  • [7] The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes
    King, P
    Peacock, I
    Donnelly, R
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (05) : 643 - 648
  • [8] Risk factors for stroke in type 2 diabetes mellitus - United Kingdom prospective diabetes study (UKPDS) 29
    Davis, TME
    Millns, H
    Stratton, IM
    Holman, RR
    Turner, RC
    ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) : 1097 - 1103
  • [9] The United Kingdom Prospective Diabetes Study (UKPDS) implications for the pharmacotherapy of type 2 diabetes mellitus
    Bretzel, RG
    Voigt, K
    Schatz, H
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1998, 106 (05) : 369 - 372
  • [10] External validation of the UK prospective diabetes study (UKPDS) risk engine in patients with type 2 diabetes identified in the national diabetes program in Iran
    Valipour, Mehrdad
    Khalili, Davood
    Solaymani-Dodaran, Masoud
    Motevalian, Seyed Abbas
    Khamseh, Mohammad Ebrahim
    Baradaran, Hamid Reza
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 22 (02) : 1145 - 1150
12345